Work

Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality

Year: 2015

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2015.06.019

Authors: Elizabeth C. Swanson, Pete Gillis, Nelmary Hernandez-Alvarado, Claudia Fernández-Alarcón, Megan Schmit, Jason C. Zabeli, Felix Wussow, Don J. Diamond, Mark R. Schleiss

Institutions: University of Minnesota, City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Hope Center for Neurological Disorders, City of Hope, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G1158197748, G1399237198, G1737803372, Bedside-to-Bench Research Training for Pediatric Infectious Diseases Fellows, G258100121, G4344237513, Viral immunomodulation and rational CMV vaccine design, G4710120773, G4854614939, G5062419069, HCMV Vaccine produced from BAC-MVA that Blocks Epithelial and Fibroblast Entry, G772794905, G795823422, G809027049, G9000016566, G9000072970, G9000163395, G9000303658

OpenAlex ID: W750660743

FWCI: 2.522

Cites: 50

Cited by: 36

Related to: 10